Casdin Partners GP, LLC's Form 4 filing
Biolife Solutions Inc (BLFS) · filed Aug 13, 2025
- Accession no.
- 0000919574-25-004702
- Filed
- Aug 13, 2025, 6:43 PM ET
- Trade date
- Aug 11, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $11.3M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Casdin Partners GP, LLCCIK 0001534260 | 10% Owner |
| Casdin Capital, LLCCIK 0001534261 | 10% Owner |
| Casdin EliCIK 0001534264 | 10% Owner |
| Casdin Partners Master Fund, L.P.CIK 0001534265 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 11, 2025 | Common Stock, par value $0.001 per share | SSaleDisposed | −500,000 | $22.60 | −$11,300,000 | 7,207,165 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.